💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Ignyta, Inc. (RXDX)
« Back to company indexRXDX Chatter Timeline
Stock Ticker for RXDX
Most Active Tweeters for RXDX
| User | Tweets |
|---|---|
| @ShogunTrade | 2 |
| @ShortAlgoTrades | 1 |
| @quantisnow | 1 |
| @Biotech2k1 | 1 |
| @A1Syad | 1 |
Recent Tweets for RXDX
 |
@Jiantkwazi @Biotech2k1 the old $RXDX was my first buyout. It was a good one! September 16th 2021, 6:09pm |
 |
@YuZhu4 RT @Biotech2k1: @Jiantkwazi $ERAS management made me big money back in the $RXDX days so they get the benefit of doubt from me. At least I… September 16th 2021, 6:09pm |
 |
@Biotech2k1 @Jiantkwazi $ERAS management made me big money back in the $RXDX days so they get the benefit of doubt from me. At… https://t.co/03Qrq5i8a0 September 16th 2021, 6:09pm |
 |
@quantisnow $RXDX ? SEC Form 4 filed by Luo Allison https://t.co/AZXpt0LH0g 30 seconds delayed. September 16th 2021, 12:09am |
 |
@ShortAlgoTrades Awaiting Short signal on $RXDX Stock Trading Ideas by UltraAlgo. https://t.co/BBatT4MLiL September 15th 2021, 10:09am |
 |
@RamUltraAlgo Waiting for Short signal on $RXDX https://t.co/JgJhWMsNk5 September 14th 2021, 7:09pm |
 |
@ShogunTrade $RXDX UltraAlgo Alert | Technical Pattern turning Bearish based off 15 indicators. https://t.co/OglkNkfCIu September 9th 2021, 4:09pm |
|
@ShogunTrade $RXDX UltraAlgo Alert | Technical Pattern turning Bearish based off 15 indicators. https://t.co/O3elKlFaSm September 9th 2021, 4:09pm |
 |
@shortalgotrader $RXDX Waiting for short signal https://t.co/cHOF4URXXj https://t.co/k5vctKuhgf September 9th 2021, 9:09am |
 |
@A1Syad $RXDX Trend is telling with the UltraAlgo Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw… https://t.co/2DPUDtrbwC September 9th 2021, 12:09am |
|
@RamUltraAlgo Waiting for Short signal on $RXDX https://t.co/to5L8DPXWp September 2nd 2021, 7:09pm |
|
@Jiantkwazi @Biotech2k1 @Yahoo 11 buyouts in 4 years?!?! That's gotta be a record. I've got $FTSV and the original $RXDX (Ignyta). August 24th 2021, 2:08am |
 |
@EdgarInsider Filing for 8-K [Press/News Current Report] has been made with the SEC: $RXDX Prometheus Biosciences, Inc https://t.co/ijDFZokgd1 August 23rd 2021, 9:08pm |
 |
@investor_feed $RXDX 8-K Prometheus Biosciences (23 Aug, 4:52pm) ? Other Events https://t.co/A9MA2DEoPq #RXDX #8K #PrometheusBiosciences #News August 23rd 2021, 8:08pm |
|
@ShortAlgoTrades $RXDX Waiting for Short signal on RXDX with https://t.co/eIVudYGeTp. Learn more at https://t.co/ZzhEUJ8ooJ https://t.co/RV7Y7Myi7x August 14th 2021, 11:08pm |
|
@ShogunTrade $RXDX Waiting for Short signal on RXDX with https://t.co/RbmGb6eXLz https://t.co/5YEgqA0BG6 August 14th 2021, 11:08pm |
 |
@LeeSinTrade1 $RXDX Waiting for Short signal on RXDX with https://t.co/yV6BCXxMw6 https://t.co/IwZ1DzvAeT August 14th 2021, 10:08pm |
|
@A1Syad $RXDX So easy to trade with the Short / Buy signals. Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw… https://t.co/qmSyGzNBnI August 14th 2021, 1:08am |
 |
@SwingTradeBot Rose Above 50 DMA today: $ECH $RXDX ... https://t.co/qwiJH6vr1O August 13th 2021, 6:08pm |
 |
@newsfilterio Prometheus Biosciences Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Progress $RXDX https://t.co/bSbH6kGoag August 12th 2021, 3:08am |
|
@ShortAlgoTrades $RXDX Awaiting Short signal. Got to love the UltraAlgo for beating the pump and dump game! https://t.co/psSpugVSvc August 12th 2021, 12:08am |
 |
@EZMoney_41 $RXDX Awaiting Short signal. https://t.co/9HkzQ0Wg65 August 12th 2021, 12:08am |
|
@newsfilterio Prometheus Biosciences EPS misses by $0.10, beats on revenue $RXDX https://t.co/bAXEO694CT August 12th 2021, 12:08am |
 |
@MarcJacksonLA $RXDX Prometheus Biosciences Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Progress https://t.co/yzTBPGlGuQ August 11th 2021, 9:08pm |
 |
@ethanFlare $RXDX - Prometheus Biosciences EPS misses by $0.10, beats on revenue Cap size: small, Float 40.6%, Short Interest 6… https://t.co/4vv9qe1grC August 11th 2021, 8:08pm |
|
@EdgarInsider FORM 10-Q [Quarterly Report] recently SEC filed. $RXDX Prometheus Biosciences, Inc. Prometheus Biosciences, Inc https://t.co/17aHKfiI1n August 11th 2021, 8:08pm |
|
@investor_feed $RXDX 10-Q Prometheus Biosciences (11 Aug, 4:21pm) ? 2021 Q2 Earnings https://t.co/fL8tbXgsvG #RXDX #10Q… https://t.co/CBnGpVk2BB August 11th 2021, 8:08pm |
|
@quantisnow $RXDX ? SEC Form 8-K filed by Prometheus Biosciences Inc. https://t.co/xxTDEv38m0 This insight appeared 30 second… https://t.co/CmhcW75XzV August 11th 2021, 8:08pm |
|
@EdgarInsider A new filing Form 8-K [Press/News Current Report] has been made at the SEC by $RXDX Prometheus Biosciences, Inc https://t.co/k3QFPLLZXp August 11th 2021, 8:08pm |
 |
@FlashAlert_me $RXDX [15s. delayed]: Issued Press Release on August 11, 16:01:00: Prometheus Biosciences Reports Second Quarter 20… https://t.co/WlcXQUbAJu August 11th 2021, 8:08pm |
 |
@StockNewsBot2 $RXDX Prometheus Biosciences Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Progress https://t.co/fl5dUTrV2g August 11th 2021, 8:08pm |
|
@quantisnow $RXDX ? Prometheus Biosciences Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Progre… https://t.co/gS64OsVATO August 11th 2021, 8:08pm |
 |
@stock_titan $RXDX Prometheus Biosciences Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Progress https://t.co/pKrKhFbPGL August 11th 2021, 8:08pm |
 |
@inoritrade $RXDX Waiting for Short signal on RXDX https://t.co/sk7mzpcC1R August 10th 2021, 9:08pm |
|
@Biotech2k1 @StockZombie $ERAS is the old $RXDX management team that developed Entrectinib and then sold it for a huge win. The… https://t.co/selI3YIUVj August 10th 2021, 11:08am |
|
@inoritrade $RXDX Waiting for Short signal on RXDX https://t.co/YQSmOikVBk August 10th 2021, 12:08am |
 |
@Tickeron A.I.dvisor is predicting $RXDX is about to fall. View odds of downtrend. #PrometheusBiosciences #stockmarket #stock… https://t.co/DgXEeWkXXo August 9th 2021, 11:08am |
|
@newsfilterio In Memoriam – Friend, Scientific Innovator, Advisor and Board Chair Dr. Tadataka Yamada Has Passed Away $RXDX https://t.co/xPBHiDRcGe August 7th 2021, 12:08pm |
|
@Biotech2k1 $ERAS has one of the old management teams that made me rich at least once before with my beloved $RXDX. It was one… https://t.co/suL2JOff5U August 5th 2021, 10:08pm |
 |
@sbwcws Prometheus announces chairman of the board's unexpected passing $RXDX August 5th 2021, 12:08pm |
 |
@otcdynamics $RXDX In Memoriam – Friend, Scientific Innovator, Advisor and Board Chair Dr. Tadataka Yamada Has Passed Away https://t.co/dhOB22AMRV August 5th 2021, 11:08am |
|
@FlashAlert_me $RXDX [15s. delayed]: Issued Press Release on August 05, 07:30:00: In Memoriam – Friend, Scientific Innovator, Advi… https://t.co/T3huqUtCJ2 August 5th 2021, 11:08am |
|
@StockNewsBot2 $RXDX In Memoriam – Friend, Scientific Innovator, Advisor and Board Chair Dr. Tadataka Yamada Has Passed Away https://t.co/nusM1ksgrW August 5th 2021, 11:08am |
|
@stock_titan $RXDX In Memoriam – Friend, Scientific Innovator, Advisor and Board Chair Dr. Tadataka Yamada Has Passed Away https://t.co/ixIhu2Rwyo August 5th 2021, 11:08am |
|
@inoritrade $RXDX waiting for buy signal on RXDX https://t.co/oNlPxeHMCH August 4th 2021, 12:08am |
 |
@Artificialbra1n RT @intratio: $RXDX https://t.co/stBXXXvthk Prometheus Biosciences Inc The artificial intelligence lets us believe this equity value will f… August 3rd 2021, 12:08am |
|
@MarcJacksonLA $RXDX Prometheus Biosciences Announces Initiation of APOLLO-CD Phase 2a Clinical Trial of PRA023 in ...… https://t.co/tPCaZb2z35 August 2nd 2021, 1:08pm |
|
@sbwcws Prometheus initiates APOLLO-CD Phase 2a trial of PRA023 $RXDX August 2nd 2021, 12:08pm |
 |
@Beeken_health $RXDX - Prometheus Biosciences Announces Initiation of APOLLO-CD Phase 2a Clinical Trial of PRA023 in Moderate-to-S… https://t.co/TUyumsxdVn August 2nd 2021, 12:08pm |
|
@ethanFlare $RXDX - Prometheus Biosciences initiates mid-stage PRA023 Crohn s disease trial Cap size: small, Float 49.2%, Short… https://t.co/k0W3kr7LFc August 2nd 2021, 12:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?